🔗 Share this article

An underground economy for unapproved slimming medications is propelled by social media fitness personalities and vendors on messaging platforms, based on recent findings.

Experimental Treatment Gaining Traction Online

Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are urged to message these accounts privately for source information, while also receiving discount codes.

Thriving Commerce on Social Networks

Additionally, a robust trade exists on messaging services, where communities with thousands of participants share comparison photos, administration instructions and assertions of next-day UK delivery. Sellers promote the substance there before directing buyers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Experts Express Worries

Nevertheless, doctors and chemists have warned that the sale of what remains an unlicensed drug in the UK is a cause for concern and could lead to users injecting products of unknown origin.

Some experts said the demand for the experimental drug could be linked to the increasing price of approved slimming treatments such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach pharmaceutical, advertising, and consumer laws, potentially leading to fines, legal action or imprisonment.

Service Reaction and Content Elimination

According to TikTok, the platform has removed problematic content and banned associated hashtags and search suggestions. The company stated it was committed to maintaining the service secure and investing in strengthening enforcement strategies.

Digital Marketplace Activities

Research also found communities with up to 9,000 members selling the experimental drug using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly brings up channels with numerous of users, filled with photos of slimming results, positive testimonials and step-by-step guides for preparing or injecting at home.

After moments of joining one community, a seller shared WhatsApp details, where most purchases take place. The vendor sent an guidebook and guaranteed delivery within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one inquired about weight, health issues or past usage.

Item Information and Costs

Within these groups, posts show black plastic parcels with postal service labels, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use pens usually priced at £160 for 20 milligrams. When asked how much time a pen should be used, vendors give conflicting answers varying between a several days to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for Telegram said it actively moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are administering materials they cannot confirm. Although the research behind this drug is sound, these digital products may not include what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current price rises for approved slimming drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit injections are extremely risky. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.

Her team has previously seen individuals injured by self-injection from unverified sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from Eli Lilly stated retatrutide was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly experimental substance not yet approved … may expose patients to possibly significant medical dangers”.